CANO Stock - Cano Health, Inc.
Unlock GoAI Insights for CANO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|
| Revenue | $2.74B | $1.61B | $831.58M | $361.38M |
| Gross Profit | $421.69M | $198.97M | $165.23M | $76.71M |
| Gross Margin | 15.4% | 12.4% | 19.9% | 21.2% |
| Operating Income | $-89,670,000 | $-102,605,000 | $42.64M | $10.81M |
| Net Income | $-428,389,000 | $-116,737,000 | $-71,064,000 | $-29,693,000 |
| Net Margin | -15.6% | -7.3% | -8.5% | -8.2% |
| EPS | $-87.60 | $-24.54 | $-42.75 | $-17.86 |
Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. As of December 31, 2021, it operated 130 owned medical centers and approximately 1000 affiliate providers serving approximately 227,005 members. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| August 11th 2023 | Jefferies | Downgrade | Hold | - |
| August 11th 2023 | Citigroup | Downgrade | Neutral | $0.8← $4 |
| January 6th 2023 | UBS | Downgrade | Neutral | $1.25← $12 |
| January 5th 2023 | Wolfe Research | Downgrade | Peer Perform | - |
| December 13th 2022 | BofA Securities | Resumed | Underperform | $1.5 |
| November 10th 2022 | Cowen | Downgrade | Market Perform | $3← $10 |
| November 10th 2022 | Raymond James | Downgrade | Market Perform | - |
| October 27th 2022 | Credit Suisse | Downgrade | Neutral | $5← $10 |
| September 7th 2022 | Truist | Initiation | Hold | $7 |
| June 24th 2022 | Raymond James | Initiation | Outperform | $8 |
| June 15th 2022 | BofA Securities | Downgrade | Neutral | $6← $8 |
| May 3rd 2022 | BofA Securities | Initiation | Buy | $8 |
| April 20th 2022 | UBS | Initiation | Buy | $15 |
| April 6th 2022 | Piper Sandler | Downgrade | Underweight | $5← $8.5 |
Earnings History & Surprises
CANOEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Aug 8, 2024 | — | — | — | — |
Q2 2024 | May 7, 2024 | — | — | — | — |
Q1 2024 | Mar 6, 2024 | $-17.56 | $18.00 | +202.5% | ✓ BEAT |
Q4 2023 | Nov 9, 2023 | $-18.50 | $-91.87 | -396.6% | ✗ MISS |
Q3 2023 | Aug 10, 2023 | $-9.00 | $-28.00 | -211.1% | ✗ MISS |
Q2 2023 | May 9, 2023 | $-14.00 | $-12.00 | +14.3% | ✓ BEAT |
Q1 2023 | Mar 1, 2023 | $-10.00 | $18.00 | +280.0% | ✓ BEAT |
Q4 2022 | Nov 9, 2022 | $-4.00 | $-1.00 | +75.0% | ✓ BEAT |
Q3 2022 | Aug 9, 2022 | $-4.00 | $-3.00 | +25.0% | ✓ BEAT |
Q2 2022 | May 9, 2022 | $-10.00 | $-7.00 | +30.0% | ✓ BEAT |
Q1 2022 | Mar 14, 2022 | $-1.00 | $-12.00 | -1100.0% | ✗ MISS |
Q4 2021 | Nov 9, 2021 | $-1.00 | $-2.00 | -100.0% | ✗ MISS |
Q3 2021 | Aug 12, 2021 | $-7.33 | $-22.00 | -200.0% | ✗ MISS |
Q1 2021 | Mar 31, 2021 | — | $-6.30 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-10.69 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-6.69 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-6.61 | — | — |
Frequently Asked Questions about CANO
What is CANO's current stock price?
What is the analyst price target for CANO?
What sector is Cano Health, Inc. in?
What is CANO's market cap?
Does CANO pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to CANO for comparison